首页> 外文OA文献 >Plasmodium berghei ANKA: Selection of resistance to piperaquine and lumefantrine in a mouse model
【2h】

Plasmodium berghei ANKA: Selection of resistance to piperaquine and lumefantrine in a mouse model

机译:伯氏疟原虫ANKA:在小鼠模型中对哌喹和lumantantrine的抗性选择

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have selected piperaquine (PQ) and lumefantrine (LM) resistant Plasmodium berghei ANKA parasite lines in mice by drug pressure. Effective doses that reduce parasitaemia by 90% (ED90) of PQ and LM against the parent line were 3.52 and 3.93 mg/kg, respectively. After drug pressure (more than 27 passages), the selected parasite lines had PQ and LM resistance indexes (I90) [ED90 of resistant line/ED90 of parent line] of 68.86 and 63.55, respectively. After growing them in the absence of drug for 10 passages and cryo-preserving them at −80 °C for at least 2 months, the resistance phenotypes remained stable. Cross-resistance studies showed that the PQ-resistant line was highly resistant to LM, while the LM-resistant line remained sensitive to PQ. Thus, if the mechanism of resistance is similar in P. berghei and Plasmodium falciparum, the use of LM (as part of Coartem®) should not select for PQ resistance.
机译:我们已经通过药压在小鼠中选择了对哌喹喹(PQ)和抗氟美林碱(LM)的伯氏疟原虫ANKA寄生虫品系。相对于亲本品系,使寄生性贫血的PQ和LM降低90%(ED90)的有效剂量分别为3.52和3.93 mg / kg。经过药物压力(超过27次传代)后,选定的寄生虫品系的PQ和LM抗性指数(I90)[抗性品系的ED90 /亲本品系的ED90]分别为68.86和63.55。使它们在没有药物的情况下生长10代,并在-80°C冷冻保存至少2个月后,耐药表型保持稳定。交叉电阻研究表明,耐PQ的品系对LM具有高度抗性,而耐LM的品系仍对PQ敏感。因此,如果伯氏疟原虫和恶性疟原虫的耐药机制相似,则不应选择LM(作为Coartem®的一部分)作为PQ耐药性的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号